10-QPeriod: Q3 FY2021

CARPENTER TECHNOLOGY CORP Quarterly Report for Q3 Ended Mar 31, 2021

Filed April 29, 2021For Securities:CRS

Summary

Carpenter Technology Corporation (CRS) reported a challenging third quarter for fiscal year 2021, marked by a net loss of $40.5 million, or $0.84 per diluted share, a significant decline from the $39.9 million net income in the prior year period. This downturn was primarily attributed to the ongoing impacts of the COVID-19 pandemic, which led to a 40% decrease in net sales, particularly affecting the Aerospace and Defense and Medical end-use markets. Restructuring and asset impairment charges, totaling $5.0 million in the quarter, further impacted profitability, with specific actions taken within the Additive business. Despite the near-term headwinds, the company highlighted its strong liquidity position with $244.2 million in cash and cash equivalents and an undrawn $294.6 million credit facility, indicating financial resilience. Management expressed optimism about an improving market outlook for the remainder of calendar year 2021, supported by recent contract extensions and signs of recovery in key sectors. The company continues to focus on strategic investments in areas like additive manufacturing and electrification to drive long-term growth.

Financial Statements
Beta

Key Highlights

  • 1Net sales decreased by 40% to $351.9 million in the three months ended March 31, 2021, compared to $585.4 million in the prior year period, largely due to COVID-19 impacts.
  • 2The company reported a net loss of $40.5 million ($0.84 per diluted share) for the quarter, a significant shift from a net income of $39.9 million ($0.82 per diluted share) in the same period last year.
  • 3Significant revenue declines were observed in key end-use markets, with Aerospace and Defense down 54% and Medical down 34%, reflecting the economic fallout from the pandemic.
  • 4Operating loss was $40.0 million, compared to an operating income of $58.7 million in the prior year quarter, impacted by lower volumes and restructuring charges.
  • 5Restructuring and asset impairment charges amounted to $5.0 million, primarily related to actions within the Additive business.
  • 6The company maintained a strong liquidity position with $244.2 million in cash and cash equivalents and $294.6 million available under its credit facility as of March 31, 2021.
  • 7Despite current challenges, management anticipates improving end-use market conditions throughout calendar year 2021.

Frequently Asked Questions

The primary driver of the financial decline was the significant impact of the COVID-19 pandemic, which led to a 40% decrease in net sales, particularly affecting the Aerospace and Defense and Medical end-use markets. Additionally, restructuring and asset impairment charges contributed to the net loss.

The company maintained a strong liquidity position, ending the quarter with $244.2 million in cash and cash equivalents. It also had $294.6 million in available borrowing capacity under its credit facility, providing ample financial resources to navigate the current economic environment.

Management is optimistic about the outlook, anticipating improving end-use market conditions throughout calendar year 2021. They highlighted recent contract extensions and signs of recovery in key sectors, supported by long-term demand for their specialized material solutions.

Yes, the company incurred $5.0 million in restructuring and asset impairment charges during the quarter, primarily related to actions taken within its Additive business. Additionally, a $52.8 million goodwill impairment charge was recorded in the prior quarter (ended December 31, 2020) for the Additive reporting unit.